IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv

IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv

Bibliographic Details
Main Authors:	Clutton, G, Bridgeman, A, Mbewe-Mvula, A, Hancock, G, Hanke, T, Dorrell, L
Format:	Conference item
Published:	2013

Similar Items

Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice.
by: Ondondo, B, et al.
Published: (2013)

Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c mice
by: Ondondo, B, et al.
Published: (2013)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and ChAdV-63 in a phase I/IIa clinical trial
by: Hanke, T, et al.
Published: (2012)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
by: Ahmed, T, et al.
Published: (2012)

Recombinant DNA/MVA/ChAdV-63-elicited T cells specific for conserved regions of the HIV-1 proteome recognize HIV-1 infected cells and suppress HIV-1
by: Ahmed T, et al.
Published: (2012-09-01)

Optimizing Delivery of the HIVconsv Immunogen in Rhesus Macaques
by: Rosario, M, et al.
Published: (2011)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
by: O'Hara, G, et al.
Published: (2012)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
by: Borthwick, N, et al.
Published: (2012)

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial
by: Borthwick NJ, et al.
Published: (2012-09-01)

Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA
by: David A. Matthews, et al.
Published: (2023-07-01)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Simian adenoviruses as vaccine vectors
by: Morris, S, et al.
Published: (2016)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
by: Folegatti, P, et al.
Published: (2019)

Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
by: Hopkins, R, et al.
Published: (2011)

Optimizing HIV-1-specific CD8 + T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors
by: Hopkins, R, et al.
Published: (2011)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
by: Ashley C. Beavis, et al.
Published: (2023-07-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
by: Pedro M. Folegatti, et al.
Published: (2019-05-01)

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
by: Borthwick, N, et al.
Published: (2015)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens
by: Moyo, N, et al.
Published: (2017)

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.
by: Nathifa Moyo, et al.
Published: (2017-01-01)

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects
by: Hancock, G, et al.
Published: (2017)

Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.
by: Donahoe, S, et al.
Published: (2000)

Aiming for protective T-cell responses: A focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials
by: Hanke, T
Published: (2019)

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
by: Edmund G. Wee, et al.
Published: (2022-06-01)

The HIVconsv Vaccines Induce Polyfunctional and Highly Proliferative T Cells that Control In Vitro HIV Replication: HIV-CORE002 Phase-I Clinical Trial
by: Ondondo, B, et al.
Published: (2013)

Parallel induction of CH505 B cell ontogeny-guided neutralizing antibodies and tHIVconsvX conserved mosaic-specific T cells against HIV-1
by: Wee, E, et al.
Published: (2019)

Simian adenoviruses: Molecular and serological survey in monkeys and humans in Thailand
by: Nathamon Kosoltanapiwat, et al.
Published: (2022-12-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
by: Antrobus, R, et al.
Published: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
by: Antrobus, R, et al.
Published: (2014)

Regulatory cytokine effects in vitro on the phenotype of subpopulations CD62L+CD63-, CD62L+CD63+ and microbicidal activity of neutrophilic granulocytes in patients with colorectal cancer
by: G. A. Chudilova, et al.
Published: (2020-12-01)

Isolation of a novel monkey adenovirus reveals a new phylogenetic clade in the evolutionary history of simian adenoviruses
by: Bofill-Mas Silvia, et al.
Published: (2011-03-01)

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
by: Gilbert, S, et al.
Published: (2017)

Regulation of zebrafish hatching by tetraspanin cd63.
by: Michael Z Trikić, et al.
Published: (2011-01-01)

Antiviral Inhibitory Capacity of CD8+ T cells Predicts the Rate of CD4+ T-Cell Decline in HIV-1 Infection
by: Yang, H, et al.
Published: (2012)

Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.
by: Yang, H, et al.
Published: (2012)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
by: Capone, S, et al.
Published: (2010)

Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates.
by: Capone, S, et al.
Published: (2010)

LASER-INDUCED FLUORESCENCE SPECTROSCOPY OF THE CD2 (A-APPROXIMATELY 1A1) RADICAL - RENNER-TELLER EFFECT IN CH2 AND CD2
by: Ashfold, M, et al.
Published: (1982)

A Novel Simian Adenovirus Associating with Human Adenovirus Species G Isolated from Long-Tailed Macaque Feces
by: Nathamon Kosoltanapiwat, et al.
Published: (2023-06-01)

Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process
by: Maria Laura Tognoli, et al.
Published: (2023-05-01)